You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

cobimetinib

Showing 1 - 25 of 73
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Arteriovenous Malformations (Extracranial) Trial in Little Rock (Cobimetinib)

Recruiting
  • Arteriovenous Malformations (Extracranial)
  • Cobimetinib
  • Little Rock, Arkansas
    Arkansas Children's Hospital
Aug 30, 2022

Gastrointestinal Cancer Trial in New York, Providence (Cobimetinib, Hydroxychloroquine, Atezolizumab)

Active, not recruiting
  • Gastrointestinal Cancer
  • Cobimetinib
  • +2 more
  • New York, New York
  • +1 more
Nov 29, 2022

Melanoma Trial in Ottawa, Toronto, Montreal (Vemurafenib, Cobimetinib)

Active, not recruiting
  • Melanoma
  • Ottawa, Ontario, Canada
  • +2 more
Oct 25, 2022

Langerhan's Cell Histiocytosis, Juvenile Xanthogranuloma, Erdheim-Chester Disease Trial in Memphis, Houston (Cobimetinib)

Recruiting
  • Langerhan's Cell Histiocytosis
  • +6 more
  • Cobimetinib
  • Phoenix, Arizona
  • +6 more
Jan 12, 2023

Metastatic Endometrial Carcinoma, Recurrent Endometrial Carcinoma, Recurrent Fallopian Tube Carcinoma Trial (Biopsy, Biospecimen

Not yet recruiting
  • Metastatic Endometrial Carcinoma
  • +7 more
  • Biopsy
  • +5 more
  • (no location specified)
Jan 18, 2023

Disease or R Group Histiocytoses Trial in Paris (Cobimetinib, Placebo oral tablet)

Active, not recruiting
  • Disease or R Group Histiocytoses
  • Cobimetinib
  • Placebo oral tablet
  • Paris, France
    Service de Médecine interne - La Pitié Salpêtrière
Mar 21, 2022

Melanoma (Skin), Skin Cancer, Skin Melanoma Trial in Tampa (Vemurafenib, Cobimetinib)

Recruiting
  • Melanoma (Skin)
  • +3 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Dec 30, 2022

Melanoma Trial in Worldwide (Belvarafenib, Cobimetinib, Atezolizumab)

Recruiting
  • Melanoma
  • Orange, California
  • +23 more
Aug 24, 2022

Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Duarte (Cobimetinib, Enasidenib Mesylate)

Not yet recruiting
  • Recurrent Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Cobimetinib
  • Enasidenib Mesylate
  • Duarte, California
    City of Hope Medical Center
Jun 28, 2022

Solid Tumor, Haematological Malignancy, Melanoma Trial in United Kingdom (Vemurafenib, Cobimetinib)

Recruiting
  • Solid Tumor
  • +11 more
  • Belfast, United Kingdom
  • +16 more
Mar 2, 2023

Melanoma Trial in Pittsburgh (Pembrolizumab, Vemurafenib, Cobimetinib)

Terminated
  • Melanoma
  • Pittsburgh, Pennsylvania
    UPMC Cancer Center Hillman Cancer Center
Dec 10, 2021

Melanoma Trial in Napoli (Vemurafenib, Peg-interferon, Cobimetinib)

Completed
  • Melanoma
  • Napoli, Italy
    Fondazione G.Pascale
Feb 23, 2022

Locally Advanced Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8 Trial in

Not yet recruiting
  • Locally Advanced Pancreatic Adenocarcinoma
  • +6 more
  • Biopsy
  • +2 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Apr 26, 2022

Skin Squamous Cell Carcinoma, Appendix Adenocarcinoma, Rare Lesion Trial in Houston (Atezolizumab, Cobimetinib)

Active, not recruiting
  • Skin Squamous Cell Carcinoma
  • +11 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 3, 2022

Solid Tumors Trial in Worldwide (Cobimetinib)

Completed
Has Results
  • Solid Tumors
  • Cobimetinib
  • Little Rock, Arkansas
  • +16 more
Sep 14, 2022

Cancer Trial in Melbourne (Trametinib, Cobimetinib, Binimetinib)

Recruiting
  • Cancer
  • Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
Nov 4, 2022

OVARIAN CANCER Trial in Worldwide (Cobimetinib, Niraparib, Atezolizumab)

Recruiting
  • OVARIAN CANCER
  • Cobimetinib
  • +2 more
  • Tucson, Arizona
  • +28 more
Jan 10, 2023

Advanced Solid Tumor, BRAF V600 Mutation Trial in United States (ABM-1310, Cobimetinib)

Recruiting
  • Advanced Solid Tumor
  • BRAF V600 Mutation
  • San Francisco, California
  • +3 more
Dec 30, 2022

Metastatic or Locally Advanced Malignancies Trial in Germany (Vemurafenib, Cobimetinib, Atezolizumab)

Recruiting
  • Metastatic or Locally Advanced Malignancies
  • Berlin, Germany
  • +5 more
Jan 2, 2023

Recurrent Breast Inflammatory Carcinoma, Stage IV Breast Inflammatory Carcinoma Trial in Houston (Atezolizumab, Cobimetinib,

Recruiting
  • Recurrent Breast Inflammatory Carcinoma
  • Stage IV Breast Inflammatory Carcinoma
  • Houston, Texas
    M D Anderson Cancer Center
Aug 11, 2021

Stage III Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer Trial in Nashville (Atezolizumab, Cobimetinib,

Terminated
Has Results
  • Stage III Breast Cancer
  • +6 more
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
Aug 10, 2021

Metastatic Distal Bile Duct Adenocarcinoma, Metastatic Gallbladder Carcinoma, Metastatic Intrahepatic Cholangiocarcinoma Trial

Recruiting
  • Metastatic Distal Bile Duct Adenocarcinoma
  • +9 more
  • Atezolizumab
  • +6 more
  • Phoenix, Arizona
  • +28 more
Dec 31, 2022

Leukemia, Myeloid, Acute Trial in Worldwide (Cobimetinib, Idasanutlin, Venetoclax)

Completed
  • Leukemia, Myeloid, Acute
  • Cobimetinib
  • +2 more
  • Los Angeles, California
  • +16 more
Dec 13, 2021

Metastatic Melanoma Trial in United States (IN10018, Cobimetinib)

Recruiting
  • Metastatic Melanoma
  • Miami, Florida
  • +4 more
Mar 29, 2022

Sarcoma,Soft Tissue Trial in France (Cobimetinib, Atezolizumab)

Recruiting
  • Sarcoma,Soft Tissue
  • Angers, France
  • +4 more
Mar 28, 2022